Insider Transactions Reported by 16 Insiders of IMMUNIC, INC.

Symbol
IMUX on Nasdaq
Location
New York, United States

Sponsored

Quick Takeaways

  • IMUX - IMMUNIC, INC. has 16 insiders with reported activity on this page.
  • Net insider value flow over the last year: +$246,928.
  • Recent transaction rows are available for direct filing-level review.

What Changed

  • Buy value: $246,928; sell value: $0.
  • Net share flow: +335,587.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to buying over the last 12 months. Net value: +$246,928.

Buys

$246,928

Shares: 335,587

Insiders: 6

Sells

$0

Shares: 0

Insiders: 0

Net

+$246,928

Shares: +335,587

Insiders: 6

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 335,587 0 $246,928 $0 +$246,928

IMMUNIC, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Daniel Vitt CEO and Director, Director $352,548 +$11,550 +3.4% Mixed 16 Jul 2025
BVF PARTNERS L P/IL Director, Other* $260,853 Mixed 17 Feb 2026
Richard A. Rudick Director $161,055 +$100,024 +164% Filing P/S 05 Jun 2025
Joerg Neermann Director $152,000 +$76,700 +102% Filing P/S 05 Jun 2025
Glenn Whaley Chief Financial Officer $68,079 +$32,076 +89% Filing P/S 16 Jul 2025
Duane Nash Executive Chairman, Director $30,075 +$16,694 +125% Filing P/S 16 Jul 2025
Jason Tardio President and COO $9,884 +$9,884 +100% Filing P/S 16 Jul 2025
Vincent Ossipow Director Mixed 15 Jun 2022
R. Thorvald Nagel Director Mixed 17 Feb 2026
Jon Congleton Director Mixed 27 Mar 2026
Simona Skerjanec Director Mixed 05 Jun 2025
Andreas Muehler Chief Medical Officer Mixed 16 Jul 2025
Monika Maria Toernsen Director Mixed 05 Jun 2025
Jan van den Bossche Director Mixed 15 Jun 2022
Barclay A. Phillips Director Mixed 05 Jun 2025
Tamar D. Howson Director Mixed 05 Jun 2025

Top shareholders of IMMUNIC, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Vivo Opportunity Fund Holdings, L.P.
13D/G
10%
29,126,906
$17,767,413 $0 17 Feb 2026
Deep Track Capital, LP
13D/G
8.7%
11,454,000
$9,964,980 $0 17 Feb 2026
Adage Capital Management, L.P.
13D/G
10%
10,479,337
$8,697,850 +$7,537,012 30 Jun 2025
JANUS HENDERSON GROUP PLC
13D/G
10%
12,016,444
$8,531,675 +$6,622,427 28 Nov 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G
BVF PARTNERS L P/IL
10%
13,630,601
$8,314,667 +$2,345,708 12 Feb 2026
Commodore Capital LP
13D/G
9.9%
13,350,121
$8,143,574 $0 17 Feb 2026
Nantahala Capital Management, LLC
13D/G 13F
Company
8.2%
10,378,406
$7,057,316 -$174,188 31 Dec 2025
Trails Edge Capital Partners, LP
13D/G
8.7%
11,454,000
$6,986,940 $0 17 Feb 2026
683 Capital Management, LLC
13D/G
5.9%
7,500,000
$5,100,000 -$2,131,423 31 Dec 2025
Alyeska Investment Group, L.P.
13D/G
6.2%
7,500,000
$5,100,000 -$2,550,000 31 Dec 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
4.4%
3,923,763
$4,473,090 $0 31 Dec 2024
Aberdeen Group plc
13D/G 13F
Company
6.8%
8,243,941
$4,399,791 $0 31 Dec 2025
Soleus Capital Master Fund, L.P.
13D/G
5.5%
6,792,000
$4,143,120 $0 17 Feb 2026
Avidity Partners Management LP
13D/G 13F
Company
4.8%
4,699,411
$4,143,001 -$807,898 30 Sep 2025
BVF INC/IL
13F
Company
5.8%
7,652,972
$4,084,391 31 Dec 2025
13F
Focus Partners Wealth
13F
Company
2%
2,622,462
$2,291,863 31 Dec 2025
13F
Laurion Capital Management LP
13F
Company
2.9%
3,882,162
$2,071,910 31 Dec 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.6%
3,419,299
$1,824,880 31 Dec 2025
13F
Soleus Private Equity Fund III, L.P.
13D/G
Soleus Capital Management, L.P.
1.6%
1,580,007
$1,392,934 $0 30 Sep 2025
RTW INVESTMENTS, LP
13D/G
1.1%
1,026,762
$1,170,509 $0 31 Mar 2025
MORGAN STANLEY
13F
Company
1.6%
2,091,011
$1,115,973 31 Dec 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.1%
1,398,600
$746,433 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.89%
1,176,285
$627,944 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
0.77%
1,019,983
$540,592 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
0.54%
717,470
$382,913 31 Dec 2025
13F
Ikarian Capital, LLC
13F
Company
0.51%
674,662
$360,067 31 Dec 2025
13F
Daniel Vitt
3/4/5
CEO and Director, Director
mixed-class rows
2,809,877
mixed-class rows
$352,548 +$11,550 16 Jul 2025
UBS Group AG
13F
Company
0.41%
537,118
$286,822 31 Dec 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.4%
527,455
$282,000 31 Dec 2025
13F
BVF PARTNERS L P/IL
3/4/5
Director, Other*
0.32%
427,629
$260,853 17 Feb 2026
Squarepoint Ops LLC
13F
Company
0.27%
352,875
$188,329 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.25%
333,829
$178,165 31 Dec 2025
13F
STATE STREET CORP
13F
Company
0.25%
331,945
$177,159 31 Dec 2025
13F
Richard A. Rudick
3/4/5
Director
mixed-class rows
480,375
mixed-class rows
$161,055 +$100,024 05 Jun 2025
Connective Capital Management, LLC
13F
Company
0.23%
301,296
$160,802 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.22%
286,677
$153,000 31 Dec 2025
13F
Joerg Neermann
3/4/5
Director
mixed-class rows
450,000
mixed-class rows
$152,000 +$76,700 05 Jun 2025
CITADEL ADVISORS LLC
13F
Company
0.2%
266,806
$142,394 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
0.17%
225,271
$120,227 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.17%
220,727
$117,802 31 Dec 2025
13F
Seven Fleet Capital Management LP
13F
Company
0.12%
155,223
$82,843 31 Dec 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.1%
130,585
$69,693 31 Dec 2025
13F
Glenn Whaley
3/4/5
Chief Financial Officer
mixed-class rows
879,010
mixed-class rows
$68,079 +$32,076 16 Jul 2025
Strategies Wealth Advisors, LLC
13F
Company
0.08%
100,000
$53,370 31 Dec 2025
13F
HB Wealth Management, LLC
13F
Company
0.07%
91,450
$48,807 31 Dec 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.06%
76,186
$40,660 31 Dec 2025
13F
LPL Financial LLC
13F
Company
0.04%
58,050
$30,981 31 Dec 2025
13F
Duane Nash
3/4/5
Executive Chairman, Director
mixed-class rows
921,032
mixed-class rows
$30,075 +$16,694 16 Jul 2025
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
40,000
$21,348 31 Dec 2025
13F
Creative Planning
13F
Company
0.03%
35,000
$18,680 31 Dec 2025
13F

Recent Insider Transactions by Companies or Individuals for IMMUNIC, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Glenn Whaley IMUX Stock Appreciation Right Award 1,960,000 560,000 16 Jul 2025 Direct
Duane Nash IMUX Stock Appreciation Right Award 2,205,000 630,000 16 Jul 2025 Direct
Daniel Vitt IMUX Stock Appreciation Right Award 6,020,000 1,720,000 16 Jul 2025 Direct
Andreas Muehler IMUX Stock Appreciation Right Award 2,310,000 660,000 16 Jul 2025 Direct
Jason Tardio IMUX Stock Appreciation Right Award 2,310,000 660,000 16 Jul 2025 Direct
Duane Nash IMUX Common Stock Purchase 124.8% $16,694 $0.8347 20,000 36,032 13 Jun 2025 Direct
Jason Tardio IMUX Common Stock Purchase $9,884 $0.7900 12,512 12,512 05 Jun 2025 Direct
Jason Tardio IMUX Stock Option Award 598,500 598,500 05 Jun 2025 Direct
Glenn Whaley IMUX Stock Option Award 503,500 503,500 05 Jun 2025 Direct
Daniel Vitt IMUX Stock Option Award 1,558,000 1,558,000 05 Jun 2025 Direct
Duane Nash IMUX Stock Option Award 570,000 570,000 05 Jun 2025 Direct
Andreas Muehler IMUX Stock Option Award 598,500 598,500 05 Jun 2025 Direct
Tamar D. Howson IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Simona Skerjanec IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Richard A. Rudick IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Monika Maria Toernsen IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Joerg Neermann IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Barclay A. Phillips IMUX Stock Option Award 150,000 150,000 05 Jun 2025 Direct
Joerg Neermann IMUX Common Stock Purchase 17.6% $22,800 $0.7600 30,000 200,000 05 Jun 2025 Direct
Daniel Vitt IMUX Common Stock Purchase 107.1% $11,550 $0.7700 15,000 29,000 04 Jun 2025 Direct
Joerg Neermann IMUX Common Stock Purchase 70% $53,900 $0.7700 70,000 170,000 04 Jun 2025 Direct
Glenn Whaley IMUX Common Stock Purchase 89.1% $32,076 $0.7128 45,000 95,510 03 Jun 2025 Direct
Richard Alan Rudick IMUX Common Stock Purchase 163.9% $100,024 $0.6991 143,075 230,375 03 Jun 2025 Direct
Glenn Whaley IMUX Common Stock Award 98% 25,000 50,510 30 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.